Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
Top Cited Papers
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjectsBritish Journal of Clinical Pharmacology, 2013
- The Berlin definition of ARDS: an expanded rationale, justification, and supplementary materialIntensive Care Medicine, 2012
- The Novel 2009 H1N1 Influenza Virus Pandemic: Unique Considerations for Programs in Cardiothoracic TransplantationThe Journal of Heart and Lung Transplantation, 2009
- Inflammation in AtherosclerosisJACC, 2009
- SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathwayCell Research, 2008
- Diagnostic and Prognostic Utility of Brain Natriuretic Peptide in Subjects Admitted to the ICU With Hypoxic Respiratory Failure Due to Noncardiogenic and Cardiogenic Pulmonary EdemaChest, 2007
- Conversion of operating theatre from positive to negative pressure environmentJournal of Hospital Infection, 2006
- Influenza Vaccination as Secondary Prevention for Cardiovascular DiseaseJACC, 2006
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004